au.\*:("GUEVIN R")
Results 1 to 6 of 6
Selection :
DIFFERENCE IN THE DISTRIBUTION OF E ANTIGEN AMONG DIFFERENT ETHNIC GROUPS IN A POPULATION OF BLOOD DONORS.RICHER G; PHANEUF D; BOISVERT F et al.1977; CANAD. MED. J.; CANADA; DA. 1977; VOL. 116; NO 7; PP. 757-759; ABS. FR.; BIBL. 22 REF.Article
DETECTION OF SURFACE AND CORE ANTIGENS OF HEPATITIS B VIRUS IN THE LIVER OF 164 HUMAN SUBJECTS. A STUDY BY IMMUNOPEROXIDASE AND ORCEIN STAINING.LAMOTHE F; LAURENCIN PICHE J; COTE J et al.1976; GASTROENTEROLOGY; U.S.A.; DA. 1976; VOL. 71; NO 1; PP. 102-108; BIBL. 43 REF.Article
Le NSABP «national surgical adjuvant project for breast and bowel cancers» (définition, rôle, méthodologie, essais thérapeutiques, résultats, philosophie) = The NSABP «national surgical adjuvant project for breast and bowel cancers» (definition, role, methodology, clinical trial, results, philosophy)LEGAULT, S; POISSON, R; FRANCHEBOIS, P et al.Union médicale du Canada. 1985, Vol 114, Num 6, pp 468-500, issn 0041-6959Article
The importance of dose scheduling with mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancerJOLIVET, J; BELANGER, K; AYOUB, J et al.European journal of cancer. Part A. 1994, Vol 30, Num 5, pp 626-628Article
Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapyLOFTERS, W. S; PATER, J. L; NAVARI, R et al.Journal of clinical oncology. 1997, Vol 15, Num 8, pp 2966-2973, issn 0732-183XArticle
The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapyPATER, J. L; LOFTERS, W. S; NAVARI, R et al.Annals of oncology. 1997, Vol 8, Num 2, pp 181-185, issn 0923-7534Article